Trade Summary

5 days ago, 5AM Ventures V, L.P., serving as 10% owner Owner at Entrada Therapeutics, Inc. (TRDA), sold 62,811 shares at $6.88 per share, for a total transaction value of $431,829.45. Following this transaction, 5AM Ventures V, L.P. now holds 2,783,781 shares of TRDA.

This sale represents a 2.21% decrease in 5AM Ventures V, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 10, 2026 at 7:52 PM ET, 4 days after the trade was made.

Entrada Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.